4-Methylmorpholine → HCID 86606487, compound
Reaction equation
[CH2:1]([O:8][N:9]([CH2:12][C:13]1(C(O)=O)[CH2:18][C@H:17]([CH3:19])[CH2:16][C@H:15]([CH3:20])[CH2:14]1)[CH:10]=[O:11])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[NH:24]([C:26]1[N:31]=[C:30]([C:32]([F:35])([F:34])[F:33])[CH:29]=[CH:28][N:27]=1)[NH2:25].CN1CC[O:40][CH2:39]C1.C1C=NC2N(O)N=NC=2C=1.Cl.CN(C)CCCN=C=NCC>CN(C=O)C>[CH2:1]([O:8][N:9]([CH:12]([C:39]([NH:25][NH:24][C:26]1[N:31]=[C:30]([C:32]([F:35])([F:34])[F:33])[CH:29]=[CH:28][N:27]=1)=[O:40])[CH:13]1[CH2:14][C@H:15]([CH3:20])[CH2:16][C@H:17]([CH3:19])[CH2:18]1)[CH:10]=[O:11])[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
To a mixture of (3S,5R)-1-[(Benzyloxy-formyl-amino)-methyl]-3,5-dimethyl-cyclohexanecarboxylic acid (0.10 g, 0.31 mmol), 2-hydrazino-4(trifluoromethyl)pyrimidine (0.067 g, 0.37 mmol), NMM (0.095 g, 0.93 mmol) and HOAt (0.05 g, 0.37 mmol) in DMF (1 mL) at room temperature was added 1-[3-(dimethylamino)-propyl]-3-ethylcarbodiimide hydrochloride (0.072 g, 0.37 mmol). After stirring at room temperature 18 h, the reaction mixture was then purified by preparative, reverse-phase HPLC to afford the title compound as a white solid (0.10 g, 71%). MH+480.
Workup
- customthe reaction mixture was then purified by preparative, reverse-phase HPLC
Sources & evidence
- ORD record
- ord-8765d241ca2d40da985599fcb7c43dd6
- Source dataset
- uspto-grants-2008_02
- Patent number
- US07332485B2
Reaction notes
Loading…